Global Erythropoietin Drugs Market (2017-2021) - Rise in Number of Patent Expiries & Need for Cost-effective Treatment - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Erythropoietin Drugs Market 2017-2021" report to their offering.

The global erythropoietin drugs market to grow at a CAGR of 0.79% during the period 2017-2021.

The report, Global Erythropoietin Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is advent of biosimilars expected to improve the treatment rates. The growing demand for quality care has led to the increased use of erythropoietin drugs for the treatment of various diseases, including cancer and blood disorders. Countries worldwide are under pressure to address this demand without increasing healthcare expenditure. Biosimilars are likely to play a prominent role in this scenario, as unlike generic drugs, they have identical active pharmaceutical ingredients to their originator biologic compounds. Biosimilars are less expensive than biologics, thereby increasing accessibility. The patent expiry of biologics has led to the emergence of their biosimilars.

Key vendors

  • Amgen
  • Hoffmann-LA Roche
  • Johnson & Johnson
  • Kyowa Hakko Kirin

Other prominent vendors

  • Ahua Pharmaceutical
  • 3SBio
  • BIOSIDUS
  • Biocon
  • Boehringer Ingelheim
  • Others

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Biosimilars: Overview

PART 06: Erythropoietin: An overview

PART 07: Market landscape

PART 08: Pipeline portfolio

PART 09: Marketed products portfolio

PART 10: Market segmentation by end-user

PART 11: Market segmentation by application

PART 12: Market segmentation by product

PART 13: Geographical segmentation

PART 14: Market drivers

PART 15: Impact of drivers

PART 16: Market challenges

PART 17: Impact of drivers and challenges

PART 18: Market trends

PART 19: Vendor landscape

PART 20: Key vendor analysis

For more information about this report visit http://www.researchandmarkets.com/research/5mvxfz/global

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Liver and Kidney Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Liver and Kidney Disorders Drugs